GB0107373A
GB0107373D0
(en)
|
2001-03-23 |
2001-03-23 |
Aplidine
|
MXPA03003230A
MXPA03003230A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector.
|
EP01974510A
EP1330254B1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with carnitine or acetylcarnitine
|
NZ525196A
NZ525196A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
CNA018204740A
CN1479622A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with myoprotector
|
CZ2003993A
CZ2003993A3
(en)
|
2000-10-12 |
2001-10-12 |
Medicament for treating cancer by administration of aplidine or aplidine analog and bone musculature protector
|
PL01361179A
PL361179A1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
AU2001294024A
AU2001294024C1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
RU2003113210/14A
RU2003113210A
(en)
|
2000-10-12 |
2001-10-12 |
TREATMENT OF CANCER DISEASES
|
JP2002533881A
JP2004510824A
(en)
|
2000-10-12 |
2001-10-12 |
Cancer Treatment
|
CA002424823A
CA2424823A1
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
HU0302293A
HUP0302293A3
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
IL15527301A
IL155273A0
(en)
|
2000-10-12 |
2001-10-12 |
Pharmaceutical compositions comprising an aplidine compound
|
ES01974510T
ES2243555T3
(en)
|
2000-10-12 |
2001-10-12 |
CANCER TREATMENT BY APLIDINE IN CONJUNCTION WITH CARNITINE OR ACETILCARNITINE.
|
AU9402401A
AU9402401A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
BR0114604-1A
BR0114604A
(en)
|
2000-10-12 |
2001-10-12 |
Cancer treatment
|
KR10-2003-7005081A
KR20030038812A
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
AT01974510T
ATE299028T1
(en)
|
2000-10-12 |
2001-10-12 |
TREATMENT OF CANCER DISEASES WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
|
US10/398,835
US7507766B2
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers
|
DE60111858T
DE60111858T2
(en)
|
2000-10-12 |
2001-10-12 |
TREATMENT OF CANCER DISORDERS WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
|
PCT/GB2001/004555
WO2002030441A2
(en)
|
2000-10-12 |
2001-10-12 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
NO20031673A
NO20031673L
(en)
|
2000-10-12 |
2003-04-11 |
Treatment of cancer
|
HK03106440.0A
HK1054191A1
(en)
|
2000-10-12 |
2003-09-10 |
Treatment of cancers by aplidine in conjunction with a myoprotector
|
JP2009255266A
JP2010031043A
(en)
|
2000-10-12 |
2009-11-06 |
Treatment of cancer
|